Gordon Yang Guang
Private Equity Investor at Infinity Equity Capital Ltd. (China)
Profile
Mr. Yang Guang joined in Infinity in 2019.
He based in Shanghai, with various experience in TMT investment, investment banking and communications engineering industry.
Now he focuses on investment opportunities on ICT and Semiconductor field.
Before joining Infinity Group, Guang worked as senior consultant and senior business development manager in IBM and Huawei.
He also worked as strategy development and investment in Wanxiang group and investment intern in Walden international.
Guang received his MBA degree from Fudan-MIT Sloan International MBA Program and holds a master degree in communication and information system.
Gordon Yang Guang active positions
| Companies | Position | Start |
|---|---|---|
| Infinity Equity Capital Ltd. (China) | Private Equity Investor | - |
Former positions of Gordon Yang Guang
| Companies | Position | End |
|---|---|---|
Huawei Hengyuan (Beijing) Biomedical Technology Co., Ltd.
 Huawei Hengyuan (Beijing) Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Huawei Hengyuan (Beijing) Biomedical Technology Co., Ltd. engages in the preparation of sertoli cells and provides biomedical technological research services. The company was founded by Jian Lin Liang on December 4, 2018 and is headquartered in Beijing, China. | Sales & Marketing | - |
| IBM | Sales & Marketing | - |
Training of Gordon Yang Guang
| Fudan University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IBM | Technology Services |
| Private companies | 2 |
|---|---|
| Infinity Equity Capital Ltd. (China) | Finance |
Huawei Hengyuan (Beijing) Biomedical Technology Co., Ltd.
Huawei Hengyuan (Beijing) Biomedical Technology Co., Ltd. BiotechnologyHealth Technology Huawei Hengyuan (Beijing) Biomedical Technology Co., Ltd. engages in the preparation of sertoli cells and provides biomedical technological research services. The company was founded by Jian Lin Liang on December 4, 2018 and is headquartered in Beijing, China. | Health Technology |
- Stock Market
- Insiders
- Gordon Yang Guang
